<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220411054501N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-04-25</date_registration>
      <primary_sponsor>Zanjan University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of the effectiveness of LASER with Aphtogel in the treatment of aphthous ulcers of the oral mucosa</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the effectiveness of 810 nm Diode LASER with Aphtogel mucoadhesive in the treatment of minor aphthous ulcers of oral mucosa (changes in diameter and pain of aphthous ulcers) in patients with minor aphthous ulcers</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-04-29</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>50</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/62923</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Not randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Blinding description: Patients are given a general explanation about the intervention methods, but one method is not introduced as superior to the other method and no preference is given to one of the interventions, so patients are blind to the effect of the intervention.</study_design>
      <phase>3</phase>
      <hc_freetext>Minor aphthous ulcer of the oral mucosa.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Patients in this group will be exposed to Diode LASER (elexion) with a wavelength of 810 nm and a power of 0.5 watts in continuous mode with a fiber diameter of 320 μm and a total energy received of 12.9 joules per square centimeter for 3 days, 3 times a day and each time for 20 seconds with an interval of 10 seconds in an area 1.5 cm in diameter around the lesion at a distance of 1 cm from the tip of the fiber from the surface of the pest sores on their wounds. Intervention 2: Intervention group: This treatment is performed using Aphthogel, which is a mucoadhesive with plant base containing Licorice plant extract. This drug is produced by Exir Danesh Asia Company. The mucoadhesive is packed in the form of 25 adhesives. Each of these adhesives is in the form of a thin layer (less than 1 mm thick) with dimensions of 1 cm2. This mucoadhesive is applied directly to the oral plague.Instructions for using the mucoadhesive (Aphthogel) are explained to the patient as follows : 1. Open the package first. 2. Remove one of the labels and carefully place it on the pest. 3. Moisturize it with saliva, the Aphthogel easily adheres to the pest. 4. The label stays on the pest for 25-30 minutes and then the rest is removed.(Swallowing the drug is not prohibited) 5. Repeat this operation 4 times a day. Use of mucoadhesive continues until complete recovery.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All data can be shared potentially except the data that leads to identifiable individuals.

When:
Access period starts 6 months after the results are published.

To whom:
The data will be available only to researchers working in academic and scientific institutions.

Conditions:
Any kind of statistical analysis is allowed on the delivered data.

Where to obtain:
Dr Robab Noormohammadi , dr.noormohammadi@zums.ac.ir

How to obtain:
The applicant can submit his request via the said email. The requested files will be sent to him as soon as possible.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Robab Noormohammadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Unit 7, Nasim Building, Deljoui St., East Zeinabieh St., Middle Saadi</address>
        <city>Zanjan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4514667092</zip>
        <telephone>+98 24 3336 5508</telephone>
        <email>dr.noormohammadi@zums.ac.ir</email>
        <affiliation>Zanjan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Robab Noormohammadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Unit 7, Nasim Building, Deljoui St., East Zeinabieh St., Middle Saadi</address>
        <city>Zanjan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4514667092</zip>
        <telephone>+98 24 3336 5508</telephone>
        <email>dr.noormohammadi@zums.ac.ir</email>
        <affiliation>Zanjan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients referred to the clinic of Zanjan Dental School who have minor aphthous ulcers of the oral mucosa.
Patients should be 10 to 80 years old.
Complete the informed consent form by the patient</inclusion_criteria>
      <agemin>10 years</agemin>
      <agemax>80 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Being a smoker
Having a systemic disease predisposing to aphthous ulcers</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Patients in this group will be exposed to Diode LASER (elexion) with a wavelength of 810 nm and a power of 0.5 watts in continuous mode with a fiber diameter of 320 μm and a total energy received of 12.9 joules per square centimeter for 3 days, 3 times a day and each time for 20 seconds with an interval of 10 seconds in an area 1.5 cm in diameter around the lesion at a distance of 1 cm from the tip of the fiber from the surface of the pest sores on their wounds.</i_keyword>
      <i_keyword>Intervention group: This treatment is performed using Aphthogel, which is a mucoadhesive with plant base containing Licorice plant extract. This drug is produced by Exir Danesh Asia Company. The mucoadhesive is packed in the form of 25 adhesives. Each of these adhesives is in the form of a thin layer (less than 1 mm thick) with dimensions of 1 cm2. This mucoadhesive is applied directly to the oral plague.Instructions for using the mucoadhesive (Aphthogel) are explained to the patient as follows : 1. Open the package first. 2. Remove one of the labels and carefully place it on the pest. 3. Moisturize it with saliva, the Aphthogel easily adheres to the pest. 4. The label stays on the pest for 25-30 minutes and then the rest is removed.(Swallowing the drug is not prohibited) 5. Repeat this operation 4 times a day. Use of mucoadhesive continues until complete recovery.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The rate of pest diameter changes in the two intervention groups. Timepoint: Measuring the pest diameter on the first, second and third days. Method of measurement: Dental gauge.</prim_outcome>
      <prim_outcome>The amount of spontaneous pain in the two intervention groups. Timepoint: Measuring the amount of spontaneous pain on the first, second and third days. Method of measurement: VAS diagram describing the amount of pain.</prim_outcome>
      <prim_outcome>The amount of functional pain in the two intervention groups. Timepoint: Measurement of the amount of functional pain in the first, second and third days of lesion. Method of measurement: VAS diagram describing the amount of pain.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Zanjan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-04-10</approval_date>
        <contact_name>Ethics Committee of Zanjan University of Medical Sciences</contact_name>
        <contact_address>The headquarters of Zanjan University of Medical Sciences, at the beginning of Jomhuri Eslami Boulevard, Azadi Square, Zanjan Zanjan Zanjan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
